Shih, Yu-ShanYu-ShanShihTsai, Wan-TingWan-TingTsaiGuo, Bei-ChiaBei-ChiaGuoARISTINE CHENGJANN-TAY WANG2025-02-182025-02-182025-02-05https://scholars.lib.ntu.edu.tw/handle/123456789/725299Neutralizing anti-interferon (IFN)-α autoantibodies can lead to immune dysregulation, potentially resulting in critical coronavirus disease 2019 (COVID-19). We report a case presenting with severe COVID-19 who was subsequently diagnosed to have thymoma and neutralizing anti-IFN-α autoantibodies.enAnti-IFN-α autoantibodiesCritical COVID-19ThymomaType 1 interferonsViral infections[SDGs]SDG3journal article10.1016/j.jmii.2025.02.00239929767